GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
48 hedge funds and large institutions have $38.5M invested in Genocea Biosciences, Inc. in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
53% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 15
Holders
48
Holding in Top 10
1
Calls
$1.21M
Puts
–
Top Buyers
| 1 | +$323K | |
| 2 | +$179K | |
| 3 | +$97K | |
| 4 |
Renaissance Technologies
New York
|
+$64.4K |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$26K |
Top Sellers
| 1 | -$1.37M | |
| 2 | -$343K | |
| 3 | -$223K | |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
-$152K |
| 5 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$146K |